Akebia Price To Sales Ratio from 2010 to 2024

AKBA Stock  USD 2.06  0.01  0.49%   
Akebia Ther's Price To Sales Ratio is decreasing over the years with slightly volatile fluctuation. Price To Sales Ratio is expected to dwindle to 1.13. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Akebia Ther's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
1.19439714
Current Value
1.13
Quarterly Volatility
131.13923308
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Akebia Ther financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akebia Ther's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.5 M, Interest Expense of 9.4 M or Selling General Administrative of 3.1 M, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or Days Sales Outstanding of 70.0. Akebia financial statements analysis is a perfect complement when working with Akebia Ther Valuation or Volatility modules.
  
Check out the analysis of Akebia Ther Correlation against competitors.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

Latest Akebia Ther's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Akebia Ther over the last few years. Price to Sales Ratio is figured by comparing Akebia Ther stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Akebia Ther sales, a figure that is much harder to manipulate than other Akebia Ther multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Akebia Ther's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akebia Ther's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.65 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Akebia Price To Sales Ratio Regression Statistics

Arithmetic Mean120.35
Geometric Mean16.61
Coefficient Of Variation108.97
Mean Deviation126.41
Median3.63
Standard Deviation131.14
Sample Variance17,197
Range255
R-Value(0.87)
Mean Square Error4,567
R-Squared0.75
Significance0.000027
Slope(25.45)
Total Sum of Squares240,765

Akebia Price To Sales Ratio History

2024 1.13
2023 1.19
2022 0.36
2021 1.76
2020 1.31
2019 2.23
2018 3.11

About Akebia Ther Financial Statements

Akebia Ther stakeholders use historical fundamental indicators, such as Akebia Ther's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Akebia Ther investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akebia Ther's assets and liabilities are reflected in the revenues and expenses on Akebia Ther's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akebia Ther. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 1.19  1.13 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:
Check out the analysis of Akebia Ther Correlation against competitors.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.22)
Revenue Per Share
0.834
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.09)
Return On Equity
(5.53)
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.